Company Overview and News

1
SPLS / Staples, Inc. SC TO-C

2018-09-14 sec.gov
SC TO-C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SPLS

1
SPLS / Staples, Inc. SC TO-C

2018-09-14 sec.gov
SC TO-C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SPLS

1
SPLS / Staples, Inc. DFAN14A

2018-09-14 sec.gov
DFAN14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION
SPLS

1
SPLS / Staples, Inc. DFAN14A

2018-09-14 sec.gov
DFAN14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION
SPLS

1
SPLS / Staples, Inc. DFAN14A

2018-09-11 sec.gov
DFAN14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION
SPLS

1
SPLS / Staples, Inc. DFAN14A

2018-09-11 sec.gov
DFAN14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION
SPLS

1
SPLS / Staples, Inc. DFAN14A

2018-09-04 sec.gov
DFAN14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION
SPLS

1
SPLS / Staples, Inc. DFAN14A

2018-09-04 sec.gov
DFAN14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION
SPLS

1
SPLS / Staples, Inc. PREC14A

2018-09-04 sec.gov
PREC14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION
SPLS

1
SPLS / Staples, Inc. PREC14A

2018-09-04 sec.gov
PREC14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION
SPLS

5
Bet on These ETFs for Back-to-School Shopping

2018-08-20 zacks
As back-to-school season has entered its peak month, retailers are on the edge with initiatives to perk up sales. This is the second-busiest shopping season (mid July to mid September) after the Christmas holidays, with sales generally picking up in mid August. This year, back-to-college spending is expected to be at its highest level ever while back-to-school spending is expected to see one of the three highest years on record.
ONLN UA TGT TXN RTH UAA AAPL SPLS XRT

69
What Marijuana and Airbnb Have to Do With New Jersey’s Tax Debate - Bloomberg

2018-06-26 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
HD JBK GSC TFG SPLS GSJ GS GLSSP GJS

3
Here Comes the Lifeboat for GameStop Stock

2018-06-20 investorplace
The market has had a rough run over the past several days. But one stock bucking the general downward trend is GameStop (NYSE:GME).
SPLS GME

60
When a work emergency strikes, this tool will get you out of bed

2018-04-19 sfgate
As the corporate world reckons with an always-on work culture, some of the world’s biggest companies are turning to a tool made by a San Francisco startup that automatically alerts employees to issues round-the-clock.
ALL GJT NOW SPLS NFLX

62
When a Work Emergency Strikes, This Tool Will Get You Out of Bed - Bloomberg

2018-04-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
GJT NOW SPLS NFLX ALL GPS

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to SPLS / Staples, Inc. on message board site Silicon Investor.

News for Staples Stock owners. News for Staples Stock owners. News for Staples Stock owners. Office Product Stocks - ODP/SPLS/OMX/VKNG/CEXP/OFIS/BOP Office Product Stocks - ODP/SPLS/OMX/VKNG/CEXP/OFIS/BOP Office Product Stocks - ODP/SPLS/OMX/VKNG/CEXP/OFIS/BOP
Staples (SPLS) Staples (SPLS) Staples (SPLS) Staples spls Staples spls Staples spls
CUSIP: 855030102